Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

33
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

764
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Diabetic Nephropathy01:28

Diabetic Nephropathy

32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

702
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
702
Diabetic Retinopathy01:27

Diabetic Retinopathy

55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Erasmus-Polyneuropathy Symptom Score for the Screening of Chronic Axonal Polyneuropathy: A Validation Study.

Journal of the peripheral nervous system : JPNS·2026
Same author

Bi- and Mono-Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy.

Annals of clinical and translational neurology·2026
Same author

Message From the Editors to Our Reviewers.

Neurology·2026
Same author

Comparing In-Person to Tele-Exercise High-Intensity Interval Training in Adults With Class II/III Obesity.

AACE endocrinology and diabetes·2026
Same author

Long-term outcomes in patients with postural orthostatic tachycardia syndrome with an average follow-up of over 20 years.

Journal of internal medicine·2026
Same author

Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis.

Annals of clinical and translational neurology·2026

Related Experiment Video

Updated: Apr 30, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.6K

Painful diabetic neuropathy.

Amanda Peltier1, Stephen A Goutman, Brian C Callaghan

  • 1Department of Neurology, Vanderbilt University, Nashville, TN, USA.

BMJ (Clinical Research Ed.)
|May 8, 2014
PubMed
Summary

Diabetic neuropathy is a costly complication. Glucose control effectively prevents neuropathy in type 1 diabetes, but less so in type 2, highlighting the need for distinct treatment strategies.

Area of Science:

  • Neurology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic neuropathy is a major complication of diabetes, leading to significant disability and cost.
  • Rising prevalence of painful diabetic neuropathy necessitates improved diagnostic and treatment approaches.
  • Understanding pathophysiologic differences between type 1 and type 2 diabetes is crucial for effective management.

Purpose of the Study:

  • To review current diagnostic methods for diabetic neuropathy.
  • To discuss established and emerging treatments for painful diabetic neuropathy.
  • To explore differences in neuropathy development and prevention between type 1 and type 2 diabetes.

Main Methods:

  • Review of evolving diagnostic techniques, including skin biopsies for fiber measurement.

More Related Videos

Rapid Determination of the Thermal Nociceptive Threshold in Diabetic Rats
05:45

Rapid Determination of the Thermal Nociceptive Threshold in Diabetic Rats

Published on: May 17, 2012

27.3K
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

12.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.6K
Rapid Determination of the Thermal Nociceptive Threshold in Diabetic Rats
05:45

Rapid Determination of the Thermal Nociceptive Threshold in Diabetic Rats

Published on: May 17, 2012

27.3K
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

12.7K
  • Analysis of current therapeutic strategies, focusing on glycemic control and pain relief medications.
  • Examination of emerging evidence on type 1 vs. type 2 diabetes and their impact on neuropathy.
  • Main Results:

    • Advanced diagnostic tests can now assess both small and large nerve fibers.
    • Glycemic control is more effective in preventing neuropathy in type 1 diabetes than in type 2.
    • Metabolic syndrome may influence neuropathy in type 2 diabetes, warranting further investigation.

    Conclusions:

    • Diabetic neuropathy requires tailored diagnostic and treatment approaches based on diabetes type.
    • Further research into the pathophysiologic differences between type 1 and type 2 diabetes is essential.
    • Optimal drug sequencing and combinations for neuropathic pain management require further determination.